Analysen von Florent Cespedes
| 30.09.15 | Merck Hold | Société Générale Group S.A. (SG) | |
| 21.09.15 | Bayer Hold | Société Générale Group S.A. (SG) | |
| 10.09.15 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
| 07.09.15 | Bayer Hold | Société Générale Group S.A. (SG) | |
| 04.09.15 | Bayer Hold | Société Générale Group S.A. (SG) | |
| 01.09.15 | Bayer Hold | Société Générale Group S.A. (SG) | |
| 30.07.15 | GSK Sell | Société Générale Group S.A. (SG) | |
| 30.07.15 | Bayer Hold | Société Générale Group S.A. (SG) | |
|
Werbung
|
|||
| 03.07.15 | Sanofi buy | Société Générale Group S.A. (SG) | |
| 26.06.15 | Bayer Hold | Société Générale Group S.A. (SG) | |
| 16.04.15 | Sanofi buy | Société Générale Group S.A. (SG) | |
| 16.04.15 | Bayer Hold | Société Générale Group S.A. (SG) | |
| 19.09.14 | Bayer Outperform | BNP PARIBAS | |
| 04.09.14 | Sanofi Outperform | BNP PARIBAS | |
| 04.09.14 | Novartis Outperform | BNP PARIBAS | |
| 01.08.14 | Sanofi Outperform | BNP PARIBAS | |
| 24.07.14 | GSK Underperform | BNP PARIBAS | |
| 27.05.14 | Novartis Outperform | BNP PARIBAS | |
| 27.05.14 | GSK Underperform | BNP PARIBAS | |
| 02.05.14 | Bayer Outperform | BNP PARIBAS | |
| 17.03.14 | STADA Neutral | BNP PARIBAS | |
| 17.03.14 | Merck Neutral | BNP PARIBAS | |
| 17.03.14 | AstraZeneca Neutral | BNP PARIBAS | |
| 17.03.14 | Bayer Outperform | BNP PARIBAS | |
| 24.08.12 | Ipsen neutral | Exane-BNP Paribas SA | |
| 24.08.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 24.08.12 | GSK outperform | Exane-BNP Paribas SA | |
| 23.08.12 | Merck neutral | Exane-BNP Paribas SA | |
| 22.08.12 | Ipsen neutral | Exane-BNP Paribas SA | |
| 10.08.12 | STADA neutral | Exane-BNP Paribas SA | |
| 10.08.12 | Novo Nordisk neutral | Exane-BNP Paribas SA | |
| 08.08.12 | Elan neutral | Exane-BNP Paribas SA | |
| 06.08.12 | STADA neutral | Exane-BNP Paribas SA | |
| 03.08.12 | Teva Pharmaceutical Industries outperform | Exane-BNP Paribas SA | |
| 02.08.12 | Shire outperform | Exane-BNP Paribas SA | |
| 01.08.12 | Bayer neutral | Exane-BNP Paribas SA | |
| 27.07.12 | Sanofi outperform | Exane-BNP Paribas SA | |
| 27.07.12 | Roche outperform | Exane-BNP Paribas SA | |
| 27.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 26.07.12 | Bayer neutral | Exane-BNP Paribas SA | |
| 26.07.12 | Novo Nordisk (spons. ADRs) neutral | Exane-BNP Paribas SA | |
| 26.07.12 | Elan neutral | Exane-BNP Paribas SA | |
| 26.07.12 | GSK outperform | Exane-BNP Paribas SA | |
| 25.07.12 | Elan neutral | Exane-BNP Paribas SA | |
| 20.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 19.07.12 | GSK outperform | Exane-BNP Paribas SA | |
| 18.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 18.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 18.07.12 | Shire outperform | Exane-BNP Paribas SA | |
| 16.07.12 | Actelion outperform | Exane-BNP Paribas SA | |